SHEILA DWYER: Open Payments
NPI 1104337518 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 17 payments from 11 companies in 2025. Trend: 2023 $253 · 2024 $550 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $91 |
| Lilly USA, LLC | 3 | $49 |
| Dexcom, Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Exact Sciences Corporation | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
Products named: MOUNJARO, Dexcom G6 Transmitter, FREESTYLE LIBRE, FARXIGA, Cologuard Collection Kit, VRAYLAR, Ozempic, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
